Chimeric antigen receptor natural Killer cell therapy(Orgenesis)

N/A

Report date: 2023/04/18 17:38:01

Base Information

Drug NameChimeric antigen receptor natural Killer cell therapy(Orgenesis)

Drug Alias NameN/A

ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy > Chimeric antigen receptor NK cell therapy

Mechanisms of ActionImmunologic cytotoxicityNatural killer cell replacements

TargetsNot applicable

Therapy Area/IndicationsOvarian NeoplasmsMultiple Myeloma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesOrgenesis Inc

China Registration ClassN/A

Develop Information

Active CompaniesOrgenesis Inc

Inactive CompaniesN/A

Active IndicationsOvarian NeoplasmsMultiple Myeloma

Inactive IndicationsN/A

Other Information

ATC CodeN/A